Xontogeny, LLC

Insider Reports History

Location
New York, NY
Signature
/s/ Christopher Garabedian for Xontogeny, LLC, By: Christoph Garabedian, its Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Xontogeny, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Landos Biopharma, Inc. Director Stock Option (Right to Buy) 10,709 27 Aug 2021 Indirect

Insider Reports Filed by Xontogeny, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924321034680-xontogeny-llc-2021-08-27 Landos Biopharma, Inc. 27 Aug 2021 1 $0 4 Director 31 Aug 2021, 21:35